Brutini

Brutini uses and dosage

Brutini (Ibrutinib), generic Imbruvica is a prescription medicine used to treat certain cancers such as Mantle cell lymphoma (MCL), Chronic lymphocytic leukemia (CLL)/ small lymphocytic lymphoma, Marginal zone lymphoma (MZL), Waldenstrom macroglobulinemia, Chronic graft-versus-host (cGVHD) disease. Brutini manufactured by Ziska Pharmaceuticals Ltd. in Bangladesh. Ibrutinib has to take orally once daily with a glass of water.

Brutini side effects

The most common adverse reactions of Ibrutinib are: Thrombocytopenia, diarrhea, neutropenia, anemia, fatigue, musculoskeletal pain, peripheral edema, upper respiratory tract infection, nausea, bruising, dyspnea, constipation, skin rash, abdominal pain, vomiting, and loss of appetite.

Originator brand

Imbruvica by Pharmacyclics

Made by

Ziska Pharma

This information is provided for reference only and is not medical advice. Always consult a qualified healthcare professional.